Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin-Reference-Cited by-同舟云学术

Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin

Published:1991-11 Issue:11 Volume:27 Page:1380-1382
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Rougier Ph.,Oliveira J.,Ducreux M.,Theodore C.,Kac J.,Droz J.P.

Publisher

Elsevier BV

Subject

Oncology

Reference10 articles.

1. Cancer statistics;Silverberg;Cancer 1989,1989

2. An odyssey in the land of small tumours;Moertel;J Clin Oncol,1989

3. Chemotherapy for metastatic carcinoid tumors;Legha,1977

4. Doxorubicin plus cisplatin in the treatment of apudomas;Sridhar;Cancer,1985

5. Combination chemotherapy of metastatic carcinoid tumours with 5-FU, adriamycin and cytoxan (FAC) and 5-FU, adriamycin, mitomycin-c, and methyl CCNU (FAMMe);Ajani,1983

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update;Expert Opinion on Pharmacotherapy;2018-04-25

2. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?;Cancer Treatment Reviews;2016-03

3. Insulinoma: Literature’s Review (2);Endocrinology&Metabolism International Journal;2015-11-19

4. Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate;Journal of Nuclear Medicine;2014-01-16

5. New Knowledge in the Diagnosis and Medical Treatment of Pancreatic Neuroendocrine Tumors;What’s New in Surgical Oncology;2013